Skip to contentC
Cryo Cell International Inc
C
CCELCryo Cell International Inc Q2 2015 · 10-Q
Revenue$5.01M$5.01M+2.5% vs Q2 2014 Net Income$210.03K$210.03K−2.7% vs Q2 2014 EPS Diluted$0.02$0.02±0.0% vs Q2 2014 Operating Income$602,091+7.1% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cryo Cell International Inc · CIK 862692 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$1,485,086+265.8% Margins · derivedOperating margin12.0%+0.5 pt vs Q2 2014
Net margin4.2%−0.2 pt vs Q2 2014
ended May 31, 2015 · filed Jul 15, 2015 · 45 d after period end